Acid steatocrit determination is not helpful in cystic fibrosis patients without or with mild steatorrhea. 2010

Jarosław Walkowiak, and Aleksandra Lisowska, and Anna Blask-Osipa, and Sławomira Drzymała-Czyz, and Paulina Sobkowiak, and Wojciech Cichy, and Anna Breborowicz, and Karl-Heinz Herzig, and Andrzej Radzikowski
Department of Gastroenterology & Metabolism, 1st Chair of Pediatrics, Poznan University of Medical Sciences, Szpitalna 27/33, 60-572 Poznań , Poland. jarwalk@am.poznan.pl

BACKGROUND Most methods used for the assessment of severe steatorrhea in cystic fibrosis (CF) are sensitive. In fact, the tests show their usefulness in a borderline zone of the results. Yet, the existing data related to acid steatocrit (AS) are still contradictory. Therefore, in the present study we have aimed to assess CF patients without or with mild steatorhea (<10 g/day) and evaluate the applicability of AS in such a subset of patients. METHODS In fifty-five CF patients, AS, fecal fat concentration (FFC) and fecal fat excretion (FFE) in 1-day stool collection were assessed from one to three times (149 samples). In 50 subjects, FFC, FFE, and AS were available for 3 subsequent days. It allowed for the calculations based upon 3-day fecal fat balance study. RESULTS The correlations between FFE/FFC and AS based upon 1-day stool collection, although statistically significant, were rather weak (r = 0.208, P < 0.011; r = 0.362, P < 0.000006, respectively). The correlations between FFE/FFC and AS based upon the 3-day stool collection, although stronger, did not show values a linear relationship (r = 0.394, P < 0.005; r = 0.454, P < 0.001, respectively). With no regard to the cut-off level for AS (10% and 20%), sensitivity, specificity, negative, and positive predictive values in the determination of abnormal FFC and FFE were not satisfactory. The flow charts describing the accuracy of AS to determine FFE and FC revealed a high level of uncertainty. CONCLUSIONS AS does not reflect in a reliable way FFE in CF patients without or mild steatorrhea. Its applicability in the assessment of FFC in such patients has therefore limited practical value.

UI MeSH Term Description Entries
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008297 Male Males
D010188 Exocrine Pancreatic Insufficiency A malabsorption condition resulting from greater than 10% reduction in the secretion of pancreatic digestive enzymes (LIPASE; PROTEASES; and AMYLASE) by the EXOCRINE PANCREAS into the DUODENUM. This condition is often associated with CYSTIC FIBROSIS and with chronic PANCREATITIS. Pancreatic Insufficiency,Exocrine Pancreatic Insufficiencies,Insufficiencies, Exocrine Pancreatic,Insufficiencies, Pancreatic,Insufficiency, Exocrine Pancreatic,Insufficiency, Pancreatic,Pancreatic Insufficiencies,Pancreatic Insufficiencies, Exocrine,Pancreatic Insufficiency, Exocrine
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003550 Cystic Fibrosis An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. Mucoviscidosis,Cystic Fibrosis of Pancreas,Fibrocystic Disease of Pancreas,Pancreatic Cystic Fibrosis,Pulmonary Cystic Fibrosis,Cystic Fibrosis, Pancreatic,Cystic Fibrosis, Pulmonary,Fibrosis, Cystic,Pancreas Fibrocystic Disease,Pancreas Fibrocystic Diseases
D005243 Feces Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

Jarosław Walkowiak, and Aleksandra Lisowska, and Anna Blask-Osipa, and Sławomira Drzymała-Czyz, and Paulina Sobkowiak, and Wojciech Cichy, and Anna Breborowicz, and Karl-Heinz Herzig, and Andrzej Radzikowski
December 1997, The American journal of gastroenterology,
Jarosław Walkowiak, and Aleksandra Lisowska, and Anna Blask-Osipa, and Sławomira Drzymała-Czyz, and Paulina Sobkowiak, and Wojciech Cichy, and Anna Breborowicz, and Karl-Heinz Herzig, and Andrzej Radzikowski
July 2018, Medicine,
Jarosław Walkowiak, and Aleksandra Lisowska, and Anna Blask-Osipa, and Sławomira Drzymała-Czyz, and Paulina Sobkowiak, and Wojciech Cichy, and Anna Breborowicz, and Karl-Heinz Herzig, and Andrzej Radzikowski
January 1987, Journal of pediatric gastroenterology and nutrition,
Jarosław Walkowiak, and Aleksandra Lisowska, and Anna Blask-Osipa, and Sławomira Drzymała-Czyz, and Paulina Sobkowiak, and Wojciech Cichy, and Anna Breborowicz, and Karl-Heinz Herzig, and Andrzej Radzikowski
August 2002, Journal of pediatric gastroenterology and nutrition,
Jarosław Walkowiak, and Aleksandra Lisowska, and Anna Blask-Osipa, and Sławomira Drzymała-Czyz, and Paulina Sobkowiak, and Wojciech Cichy, and Anna Breborowicz, and Karl-Heinz Herzig, and Andrzej Radzikowski
July 2002, The European respiratory journal,
Jarosław Walkowiak, and Aleksandra Lisowska, and Anna Blask-Osipa, and Sławomira Drzymała-Czyz, and Paulina Sobkowiak, and Wojciech Cichy, and Anna Breborowicz, and Karl-Heinz Herzig, and Andrzej Radzikowski
January 1978, Acta gastroenterologica Latinoamericana,
Jarosław Walkowiak, and Aleksandra Lisowska, and Anna Blask-Osipa, and Sławomira Drzymała-Czyz, and Paulina Sobkowiak, and Wojciech Cichy, and Anna Breborowicz, and Karl-Heinz Herzig, and Andrzej Radzikowski
January 1987, Drug intelligence & clinical pharmacy,
Jarosław Walkowiak, and Aleksandra Lisowska, and Anna Blask-Osipa, and Sławomira Drzymała-Czyz, and Paulina Sobkowiak, and Wojciech Cichy, and Anna Breborowicz, and Karl-Heinz Herzig, and Andrzej Radzikowski
July 2008, Journal of the Royal Society of Medicine,
Jarosław Walkowiak, and Aleksandra Lisowska, and Anna Blask-Osipa, and Sławomira Drzymała-Czyz, and Paulina Sobkowiak, and Wojciech Cichy, and Anna Breborowicz, and Karl-Heinz Herzig, and Andrzej Radzikowski
May 2011, The Journal of pediatrics,
Jarosław Walkowiak, and Aleksandra Lisowska, and Anna Blask-Osipa, and Sławomira Drzymała-Czyz, and Paulina Sobkowiak, and Wojciech Cichy, and Anna Breborowicz, and Karl-Heinz Herzig, and Andrzej Radzikowski
March 2022, Respiratory medicine,
Copied contents to your clipboard!